This report highlights different factors and opportunities prevailing in the “Global Amyotrophic Lateral Sclerosis Market (2024 Edition)”. According to the report, the Global Amyotrophic Lateral Sclerosis Market was valued at USD 720.66 Million and is expected to grow at a CAGR of 8.7% during 2025-2030.
The report explores a multi-faceted opportunity landscape in terms of market segmentation by Treatment Type (Medications, Respiratory Therapy, Speech Therapy, Physical Therapy and Other Treatment Types), By Drug (Edaravone, Nuedexta, Riluzole and Other Drugs) and By Distribution Channel (Online Pharmacies and Retail Pharmacies)
One of the main drivers of the ALS market is the increasing prevalence of the disease globally. According to the ALS Association, thousands of new cases are diagnosed every year, emphasizing the growing burden of this condition. This has led to increased research efforts and funding aimed at understanding the disease's pathogenesis and developing novel therapeutic options.
The market has seen notable advancements in drug development, with several promising therapies in the pipeline. Riluzole and edaravone are currently the only FDA-approved drugs for ALS, but ongoing clinical trials and research initiatives are exploring new treatment avenues. Gene therapy, stem cell therapy, and neuroprotective agents are some of the innovative approaches being investigated.
Increased awareness and advocacy efforts have also played a crucial role in the ALS market's growth. Organizations like the ALS Association and various patient advocacy groups have raised awareness about the disease, advocating for research funding and improved patient care. These efforts have not only heightened public awareness but also attracted investments from pharmaceutical companies and research institutions.
In the Americas, the market benefits from a robust healthcare system, the presence of leading pharmaceutical companies, and strong advocacy efforts. The growing focus on neurodegenerative diseases and increased funding for research further support market growth.
The Asia Pacific region is expected to witness the highest growth rate, driven by increasing healthcare investments, rising prevalence of ALS, and growing awareness of neurodegenerative disorders. Countries like Japan, China, and South Korea are key markets, with expanding healthcare infrastructure and a focus on improving patient outcomes.
In Europe, the market for ALS treatments is driven by strong regulatory support, a well-established healthcare system, and ongoing research efforts. Countries like Germany, France, and the UK are significant contributors, with a focus on developing new therapies and improving patient care.
This product will be delivered within 2 business days.
The report explores a multi-faceted opportunity landscape in terms of market segmentation by Treatment Type (Medications, Respiratory Therapy, Speech Therapy, Physical Therapy and Other Treatment Types), By Drug (Edaravone, Nuedexta, Riluzole and Other Drugs) and By Distribution Channel (Online Pharmacies and Retail Pharmacies)
Market Overview
The Amyotrophic Lateral Sclerosis (ALS) market has experienced significant growth driven by an increasing prevalence of ALS, advancements in therapeutic research, and growing awareness of neurodegenerative disorders. ALS, also known as Lou Gehrig's disease, is a progressive neurodegenerative condition that affects nerve cells in the brain and spinal cord, leading to loss of muscle control. The market's expansion is primarily fueled by the urgent need for effective treatments and improved diagnostic methods.One of the main drivers of the ALS market is the increasing prevalence of the disease globally. According to the ALS Association, thousands of new cases are diagnosed every year, emphasizing the growing burden of this condition. This has led to increased research efforts and funding aimed at understanding the disease's pathogenesis and developing novel therapeutic options.
The market has seen notable advancements in drug development, with several promising therapies in the pipeline. Riluzole and edaravone are currently the only FDA-approved drugs for ALS, but ongoing clinical trials and research initiatives are exploring new treatment avenues. Gene therapy, stem cell therapy, and neuroprotective agents are some of the innovative approaches being investigated.
Increased awareness and advocacy efforts have also played a crucial role in the ALS market's growth. Organizations like the ALS Association and various patient advocacy groups have raised awareness about the disease, advocating for research funding and improved patient care. These efforts have not only heightened public awareness but also attracted investments from pharmaceutical companies and research institutions.
Segment Insights
By drug type, the riluzole segment holds the largest market share, accounting for approximately 45% of the global ALS market in 2023. Riluzole has been a mainstay in ALS treatment due to its ability to slow disease progression.Geographical Insights
The Americas represent the largest market for ALS treatments, driven by a strong healthcare infrastructure, significant R&D activities, and a high prevalence of the disease. The United States is a key market, with extensive research initiatives and a focus on developing novel therapies.In the Americas, the market benefits from a robust healthcare system, the presence of leading pharmaceutical companies, and strong advocacy efforts. The growing focus on neurodegenerative diseases and increased funding for research further support market growth.
The Asia Pacific region is expected to witness the highest growth rate, driven by increasing healthcare investments, rising prevalence of ALS, and growing awareness of neurodegenerative disorders. Countries like Japan, China, and South Korea are key markets, with expanding healthcare infrastructure and a focus on improving patient outcomes.
In Europe, the market for ALS treatments is driven by strong regulatory support, a well-established healthcare system, and ongoing research efforts. Countries like Germany, France, and the UK are significant contributors, with a focus on developing new therapies and improving patient care.
Market Segmentation
By Treatment Type:
- Medications
- Respiratory Therapy
- Speech Therapy
- Physical Therapy
- Other Treatment Types
By Drug:
- Edaravone
- Nuedexta
- Riluzole
- Other Drugs
By Distribution Channel:
- Online Pharmacies
- Retail Pharmacies
By Geography:
- Americas (The United States, Canada, Brazil, Mexico, Rest of Americas)
- Europe (United Kingdom, Germany, France, Italy, Spain, Turkey, Russia, Rest of Europe)
- Asia Pacific (China, Japan, South Korea, India, Singapore, Indonesia, Rest of Asia Pacific)
- Middle East and Africa (GCC, Israel, South Africa, Rest of Middle East and Africa)
Key Companies
The report assesses the competitive developments, strategies, mergers and acquisitions and new product development and market share portfolio of top 15 companies. Key companies in the Global Amyotrophic Lateral Sclerosis Market include:- Biohaven Pharmaceutical
- Ionis Pharmaceuticals, Inc.
- Sun Pharmaceutical
- BrainStorm Therapeutics
- F.Hoffmann-La Roche AG
- Mitsubishi Tanabe Pharma Corporation
- Biogen Inc.
- Corestem
- Otsuka Pharmaceutical Co., Ltd.
- AB Science
- Other Leading Companies
Reasons to buy this report:
- In-Depth Comparative Assessment of Top 20 Markets in the Amyotrophic Lateral Sclerosis Market: Comparative assessment of 20 leading countries highlighting the total addressable market, opportunities, lucrative segments and competitive positioning of leading companies.
- Comprehensive Historical, Present, and Future Analytics of the Amyotrophic Lateral Sclerosis Market: A deep dive in the historical (2020-2023), current (2024) and forecast (2025-2030) market analytics of Amyotrophic Lateral Sclerosis Market.
- Detailed Analysis of Amyotrophic Lateral Sclerosis Market By Treatment Type, Drug, and Distribution Channel Across 20 Countries
- Beyond the Purchase: 90 Days of Support
- Direct Access to Analysts: Have questions after reading the report? Our expert analysts are just a call or email away.
- Customized Assistance: Whether you're integrating insights into your strategy or have questions about market dynamics, our team provides tailored support to meet your specific business needs.
- Data Customization Requests: During the support period, you have the flexibility to request additional data cuts or deeper dives into specific areas of interest.
- Gain insights specific to new entrants or new market areas to tap: The study provides detailed market entry strategies, including analysis of barriers to entry, pricing strategies, opportunities, trends, drivers, and challenges and product positioning using the Opportunity Portfolio Matrix (OPM)
- Strategic Company Movements: Tracking Competitive Developments and Key Players in the Market: The report covers competitive strategies, mergers & acquisitions, new developments, future plans and market share analysis of ~15 top companies.
This product will be delivered within 2 business days.
Table of Contents
1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
1.2 Executive Summary
1.3 Research Methodology
3. Global Amyotrophic Lateral Sclerosis Market: Historic and Forecast
3.1 Impact Analysis of Macro Economic Factors on Global Amyotrophic Lateral Sclerosis Market
3.2 Amyotrophic Lateral Sclerosis Market Type Matrix
3.3 Global Amyotrophic Lateral Sclerosis Market: Dashboard
3.4 Global Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, By Value, 2020-2030 (USD Million & CAGR)
3.5 Global Amyotrophic Lateral Sclerosis Market: Market Value Assessment
3.6 Assessment Degree of Impact of COVID-19 on Global Amyotrophic Lateral Sclerosis Market
3.7 Global Amyotrophic Lateral Sclerosis Market Segmentation: By Treatment Type
3.7.1 Global Amyotrophic Lateral Sclerosis Market, By Treatment Type Overview
3.7.2 Global Amyotrophic Lateral Sclerosis Market Attractiveness Index, By Treatment Type (2025-2030)
3.7.3 Global Amyotrophic Lateral Sclerosis Market Size, By Medications, By Value, 2020H-2030F (USD Million & CAGR)
3.7.4 Global Amyotrophic Lateral Sclerosis Market Size, By Respiratory Therapy, By Value, 2020H-2030F (USD Million & CAGR)
3.7.5 Global Amyotrophic Lateral Sclerosis Market Size, By Speech Therapy, By Value, 2020H-2030F (USD Million & CAGR)
3.7.6 Global Amyotrophic Lateral Sclerosis Market Size, By Physical Therapy, By Value, 2020H-2030F (USD Million & CAGR)
3.7.7 Global Amyotrophic Lateral Sclerosis Market Size, By Other Treatment Types, By Value, 2020H-2030F (USD Million & CAGR)
3.8 Global Amyotrophic Lateral Sclerosis Market Segmentation: By Drug
3.8.1 Global Amyotrophic Lateral Sclerosis Market, By Drug Overview
3.8.2 Global Amyotrophic Lateral Sclerosis Market Attractiveness Index, By Drug (2025-2030)
3.8.3 Global Amyotrophic Lateral Sclerosis Market Size, By Edaravone, By Value, 2020H-2030F (USD Million & CAGR)
3.8.4 Global Amyotrophic Lateral Sclerosis Market Size, By Nuedexta, By Value, 2020H-2030F (USD Million & CAGR)
3.8.5 Global Amyotrophic Lateral Sclerosis Market Size, By Riluzole, By Value, 2020H-2030F (USD Million & CAGR)
3.8.6 Global Amyotrophic Lateral Sclerosis Market Size, By Other Drugs, By Value, 2020H-2030F (USD Million & CAGR)
3.9 Global Amyotrophic Lateral Sclerosis Market Segmentation: By Distribution Channel
3.9.1 Global Amyotrophic Lateral Sclerosis Market, By Distribution Channel Overview
3.9.2 Global Amyotrophic Lateral Sclerosis Market Attractiveness Index, By Distribution Channel (2025-2030)
3.9.3 Global Amyotrophic Lateral Sclerosis Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
3.9.4 Global Amyotrophic Lateral Sclerosis Market Size, By Retail Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
3.2 Amyotrophic Lateral Sclerosis Market Type Matrix
3.3 Global Amyotrophic Lateral Sclerosis Market: Dashboard
3.4 Global Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, By Value, 2020-2030 (USD Million & CAGR)
3.5 Global Amyotrophic Lateral Sclerosis Market: Market Value Assessment
3.6 Assessment Degree of Impact of COVID-19 on Global Amyotrophic Lateral Sclerosis Market
3.7 Global Amyotrophic Lateral Sclerosis Market Segmentation: By Treatment Type
3.7.1 Global Amyotrophic Lateral Sclerosis Market, By Treatment Type Overview
3.7.2 Global Amyotrophic Lateral Sclerosis Market Attractiveness Index, By Treatment Type (2025-2030)
3.7.3 Global Amyotrophic Lateral Sclerosis Market Size, By Medications, By Value, 2020H-2030F (USD Million & CAGR)
3.7.4 Global Amyotrophic Lateral Sclerosis Market Size, By Respiratory Therapy, By Value, 2020H-2030F (USD Million & CAGR)
3.7.5 Global Amyotrophic Lateral Sclerosis Market Size, By Speech Therapy, By Value, 2020H-2030F (USD Million & CAGR)
3.7.6 Global Amyotrophic Lateral Sclerosis Market Size, By Physical Therapy, By Value, 2020H-2030F (USD Million & CAGR)
3.7.7 Global Amyotrophic Lateral Sclerosis Market Size, By Other Treatment Types, By Value, 2020H-2030F (USD Million & CAGR)
3.8 Global Amyotrophic Lateral Sclerosis Market Segmentation: By Drug
3.8.1 Global Amyotrophic Lateral Sclerosis Market, By Drug Overview
3.8.2 Global Amyotrophic Lateral Sclerosis Market Attractiveness Index, By Drug (2025-2030)
3.8.3 Global Amyotrophic Lateral Sclerosis Market Size, By Edaravone, By Value, 2020H-2030F (USD Million & CAGR)
3.8.4 Global Amyotrophic Lateral Sclerosis Market Size, By Nuedexta, By Value, 2020H-2030F (USD Million & CAGR)
3.8.5 Global Amyotrophic Lateral Sclerosis Market Size, By Riluzole, By Value, 2020H-2030F (USD Million & CAGR)
3.8.6 Global Amyotrophic Lateral Sclerosis Market Size, By Other Drugs, By Value, 2020H-2030F (USD Million & CAGR)
3.9 Global Amyotrophic Lateral Sclerosis Market Segmentation: By Distribution Channel
3.9.1 Global Amyotrophic Lateral Sclerosis Market, By Distribution Channel Overview
3.9.2 Global Amyotrophic Lateral Sclerosis Market Attractiveness Index, By Distribution Channel (2025-2030)
3.9.3 Global Amyotrophic Lateral Sclerosis Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
3.9.4 Global Amyotrophic Lateral Sclerosis Market Size, By Retail Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
4. Amyotrophic Lateral Sclerosis Market, Region Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot
4.2 Regional Snapshot
5. Americas Amyotrophic Lateral Sclerosis Market: Historic and Forecast
5.1 Americas Amyotrophic Lateral Sclerosis Market: Snapshot
5.2 Americas Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, By Value, 2020-2030 (USD Million & CAGR)
5.3 Americas Amyotrophic Lateral Sclerosis Market: Key Factors
5.4 Americas Amyotrophic Lateral Sclerosis Market: Segment Analysis
5.5 Americas Amyotrophic Lateral Sclerosis Market Segmentation: By Treatment Type
5.5.1 Americas Amyotrophic Lateral Sclerosis Market, By Treatment Type Overview
5.5.2 Americas Amyotrophic Lateral Sclerosis Market Size, By Medications, By Value, 2020H-2030F (USD Million & CAGR)
5.5.3 Americas Amyotrophic Lateral Sclerosis Market Size, By Respiratory Therapy, By Value, 2020H-2030F (USD Million & CAGR)
5.5.4 Americas Amyotrophic Lateral Sclerosis Market Size, By Speech Therapy, By Value, 2020H-2030F (USD Million & CAGR)
5.5.5 Americas Amyotrophic Lateral Sclerosis Market Size, By Physical Therapy, By Value, 2020H-2030F (USD Million & CAGR)
5.5.6 Americas Amyotrophic Lateral Sclerosis Market Size, By Other Treatment Types, By Value, 2020H-2030F (USD Million & CAGR)
5.6 Americas Amyotrophic Lateral Sclerosis Market Segmentation: By Drug
5.6.1 Americas Amyotrophic Lateral Sclerosis Market, By Drug Overview
5.6.2 Americas Amyotrophic Lateral Sclerosis Market Size, By Edaravone, By Value, 2020H-2030F (USD Million & CAGR)
5.6.3 Americas Amyotrophic Lateral Sclerosis Market Size, By Nuedexta, By Value, 2020H-2030F (USD Million & CAGR)
5.6.4 Americas Amyotrophic Lateral Sclerosis Market Size, By Riluzole, By Value, 2020H-2030F (USD Million & CAGR)
5.6.5 Americas Amyotrophic Lateral Sclerosis Market Size, By Other Drugs, By Value, 2020H-2030F (USD Million & CAGR)
5.7 Americas Amyotrophic Lateral Sclerosis Market Segmentation: By Distribution Channel
5.7.1 Americas Amyotrophic Lateral Sclerosis Market, By Distribution Channel Overview
5.7.2 Americas Amyotrophic Lateral Sclerosis Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
5.7.3 Americas Amyotrophic Lateral Sclerosis Market Size, By Retail Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
5.8 Americas Amyotrophic Lateral Sclerosis Market Segmentation: By Country
5.8.1 Americas Amyotrophic Lateral Sclerosis Market, by Country Overview
5.8.2 United States Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.2.1 United States Amyotrophic Lateral Sclerosis Market, By Treatment Type
5.8.2.2 United States Amyotrophic Lateral Sclerosis Market, By Drug
5.8.2.3 United States Amyotrophic Lateral Sclerosis Market, By Distribution Channel
5.8.3 Canada Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.3.1 Canada Amyotrophic Lateral Sclerosis Market, By Treatment Type
5.8.3.2 Canada Amyotrophic Lateral Sclerosis Market, By Drug
5.8.3.3 Canada Amyotrophic Lateral Sclerosis Market, By Distribution Channel
5.8.4 Brazil Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.4.1 Brazil Amyotrophic Lateral Sclerosis Market, By Treatment Type
5.8.4.2 Brazil Amyotrophic Lateral Sclerosis Market, By Drug
5.8.4.3 Brazil Amyotrophic Lateral Sclerosis Market, By Distribution Channel
5.8.5 Mexico Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.5.1 Mexico Amyotrophic Lateral Sclerosis Market, By Treatment Type
5.8.5.2 Mexico Amyotrophic Lateral Sclerosis Market, By Drug
5.8.5.3 Mexico Amyotrophic Lateral Sclerosis Market, By Distribution Channel
5.8.6 Rest of Americas Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.6.1 Rest of Americas Amyotrophic Lateral Sclerosis Market, By Treatment Type
5.8.6.2 Rest of Americas Amyotrophic Lateral Sclerosis Market, By Drug
5.8.6.3 Rest of Americas Amyotrophic Lateral Sclerosis Market, By Distribution Channel
5.2 Americas Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, By Value, 2020-2030 (USD Million & CAGR)
5.3 Americas Amyotrophic Lateral Sclerosis Market: Key Factors
5.4 Americas Amyotrophic Lateral Sclerosis Market: Segment Analysis
5.5 Americas Amyotrophic Lateral Sclerosis Market Segmentation: By Treatment Type
5.5.1 Americas Amyotrophic Lateral Sclerosis Market, By Treatment Type Overview
5.5.2 Americas Amyotrophic Lateral Sclerosis Market Size, By Medications, By Value, 2020H-2030F (USD Million & CAGR)
5.5.3 Americas Amyotrophic Lateral Sclerosis Market Size, By Respiratory Therapy, By Value, 2020H-2030F (USD Million & CAGR)
5.5.4 Americas Amyotrophic Lateral Sclerosis Market Size, By Speech Therapy, By Value, 2020H-2030F (USD Million & CAGR)
5.5.5 Americas Amyotrophic Lateral Sclerosis Market Size, By Physical Therapy, By Value, 2020H-2030F (USD Million & CAGR)
5.5.6 Americas Amyotrophic Lateral Sclerosis Market Size, By Other Treatment Types, By Value, 2020H-2030F (USD Million & CAGR)
5.6 Americas Amyotrophic Lateral Sclerosis Market Segmentation: By Drug
5.6.1 Americas Amyotrophic Lateral Sclerosis Market, By Drug Overview
5.6.2 Americas Amyotrophic Lateral Sclerosis Market Size, By Edaravone, By Value, 2020H-2030F (USD Million & CAGR)
5.6.3 Americas Amyotrophic Lateral Sclerosis Market Size, By Nuedexta, By Value, 2020H-2030F (USD Million & CAGR)
5.6.4 Americas Amyotrophic Lateral Sclerosis Market Size, By Riluzole, By Value, 2020H-2030F (USD Million & CAGR)
5.6.5 Americas Amyotrophic Lateral Sclerosis Market Size, By Other Drugs, By Value, 2020H-2030F (USD Million & CAGR)
5.7 Americas Amyotrophic Lateral Sclerosis Market Segmentation: By Distribution Channel
5.7.1 Americas Amyotrophic Lateral Sclerosis Market, By Distribution Channel Overview
5.7.2 Americas Amyotrophic Lateral Sclerosis Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
5.7.3 Americas Amyotrophic Lateral Sclerosis Market Size, By Retail Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
5.8 Americas Amyotrophic Lateral Sclerosis Market Segmentation: By Country
5.8.1 Americas Amyotrophic Lateral Sclerosis Market, by Country Overview
5.8.2 United States Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.2.1 United States Amyotrophic Lateral Sclerosis Market, By Treatment Type
5.8.2.2 United States Amyotrophic Lateral Sclerosis Market, By Drug
5.8.2.3 United States Amyotrophic Lateral Sclerosis Market, By Distribution Channel
5.8.3 Canada Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.3.1 Canada Amyotrophic Lateral Sclerosis Market, By Treatment Type
5.8.3.2 Canada Amyotrophic Lateral Sclerosis Market, By Drug
5.8.3.3 Canada Amyotrophic Lateral Sclerosis Market, By Distribution Channel
5.8.4 Brazil Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.4.1 Brazil Amyotrophic Lateral Sclerosis Market, By Treatment Type
5.8.4.2 Brazil Amyotrophic Lateral Sclerosis Market, By Drug
5.8.4.3 Brazil Amyotrophic Lateral Sclerosis Market, By Distribution Channel
5.8.5 Mexico Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.5.1 Mexico Amyotrophic Lateral Sclerosis Market, By Treatment Type
5.8.5.2 Mexico Amyotrophic Lateral Sclerosis Market, By Drug
5.8.5.3 Mexico Amyotrophic Lateral Sclerosis Market, By Distribution Channel
5.8.6 Rest of Americas Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.6.1 Rest of Americas Amyotrophic Lateral Sclerosis Market, By Treatment Type
5.8.6.2 Rest of Americas Amyotrophic Lateral Sclerosis Market, By Drug
5.8.6.3 Rest of Americas Amyotrophic Lateral Sclerosis Market, By Distribution Channel
6. Europe Amyotrophic Lateral Sclerosis Market: Historic and Forecast
6.1 Europe Amyotrophic Lateral Sclerosis Market: Snapshot
6.2 Europe Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, BY Value, 2020-2030 (USD Million & CAGR)
6.3 Europe Amyotrophic Lateral Sclerosis Market: Key Factors
6.4 Europe Amyotrophic Lateral Sclerosis Market: Segment Analysis
6.5 Europe Amyotrophic Lateral Sclerosis Market Segmentation: By Treatment Type
6.5.1 Europe Amyotrophic Lateral Sclerosis Market, By Treatment Type Overview
6.5.2 Europe Amyotrophic Lateral Sclerosis Market Size, By Medications, By Value, 2020H-2030F (USD Million & CAGR)
6.5.3 Europe Amyotrophic Lateral Sclerosis Market Size, By Respiratory Therapy, By Value, 2020H-2030F (USD Million & CAGR)
6.5.4 Europe Amyotrophic Lateral Sclerosis Market Size, By Speech Therapy, By Value, 2020H-2030F (USD Million & CAGR)
6.5.5 Europe Amyotrophic Lateral Sclerosis Market Size, By Physical Therapy, By Value, 2020H-2030F (USD Million & CAGR)
6.5.6 Europe Amyotrophic Lateral Sclerosis Market Size, By Other Treatment Types, By Value, 2020H-2030F (USD Million & CAGR)
6.6 Europe Amyotrophic Lateral Sclerosis Market Segmentation: By Drug
6.6.1 Europe Amyotrophic Lateral Sclerosis Market, By Drug Overview
6.6.2 Europe Amyotrophic Lateral Sclerosis Market Size, By Edaravone, By Value, 2020H-2030F (USD Million & CAGR)
6.6.3 Europe Amyotrophic Lateral Sclerosis Market Size, By Nuedexta, By Value, 2020H-2030F (USD Million & CAGR)
6.6.4 Europe Amyotrophic Lateral Sclerosis Market Size, By Riluzole, By Value, 2020H-2030F (USD Million & CAGR)
6.6.5 Europe Amyotrophic Lateral Sclerosis Market Size, By Other Drugs, By Value, 2020H-2030F (USD Million & CAGR)
6.7 Europe Amyotrophic Lateral Sclerosis Market Segmentation: By Distribution Channel
6.7.1 Europe Amyotrophic Lateral Sclerosis Market, By Distribution Channel Overview
6.7.2 Europe Amyotrophic Lateral Sclerosis Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
6.7.3 Europe Amyotrophic Lateral Sclerosis Market Size, By Retail Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
6.8 Europe Amyotrophic Lateral Sclerosis Market Segmentation: By Country
6.8.1 Europe Amyotrophic Lateral Sclerosis Market, by Country Overview
6.8.2 Russia Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.2.1 Russia Amyotrophic Lateral Sclerosis Market, By Treatment Type
6.8.2.2 Russia Amyotrophic Lateral Sclerosis Market, By Drug
6.8.2.3 Russia Amyotrophic Lateral Sclerosis Market, By Distribution Channel
6.8.3 France Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.3.1 France Amyotrophic Lateral Sclerosis Market, By Treatment Type
6.8.3.2 France Amyotrophic Lateral Sclerosis Market, By Drug
6.8.3.3 France Amyotrophic Lateral Sclerosis Market, By Distribution Channel
6.8.4 United Kingdom Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.4.1 United Kingdom Amyotrophic Lateral Sclerosis Market, By Treatment Type
6.8.4.2 United Kingdom Amyotrophic Lateral Sclerosis Market, By Drug
6.8.4.3 United Kingdom Amyotrophic Lateral Sclerosis Market, By Distribution Channel
6.8.5 Germany Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.5.1 Germany Amyotrophic Lateral Sclerosis Market, By Treatment Type
6.8.5.2 Germany Amyotrophic Lateral Sclerosis Market, By Drug
6.8.5.3 Germany Amyotrophic Lateral Sclerosis Market, By Distribution Channel
6.8.6 Italy Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.6.1 Italy Amyotrophic Lateral Sclerosis Market, By Treatment Type
6.8.6.2 Italy Amyotrophic Lateral Sclerosis Market, By Drug
6.8.6.3 Italy Amyotrophic Lateral Sclerosis Market, By Distribution Channel
6.8.7 Spain Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.7.1 Spain Amyotrophic Lateral Sclerosis Market, By Treatment Type
6.8.7.2 Spain Amyotrophic Lateral Sclerosis Market, By Drug
6.8.7.3 Spain Amyotrophic Lateral Sclerosis Market, By Distribution Channel
6.8.8 Turkey Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.8.1 Turkey Amyotrophic Lateral Sclerosis Market, By Treatment Type
6.8.8.2 Turkey Amyotrophic Lateral Sclerosis Market, By Drug
6.8.8.3 Turkey Amyotrophic Lateral Sclerosis Market, By Distribution Channel
6.8.9 Rest of Europe Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.9.1 Rest of Europe Amyotrophic Lateral Sclerosis Market, By Treatment Type
6.8.9.2 Rest of Europe Amyotrophic Lateral Sclerosis Market, By Drug
6.8.9.3 Rest of Europe Amyotrophic Lateral Sclerosis Market, By Distribution Channel
6.2 Europe Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, BY Value, 2020-2030 (USD Million & CAGR)
6.3 Europe Amyotrophic Lateral Sclerosis Market: Key Factors
6.4 Europe Amyotrophic Lateral Sclerosis Market: Segment Analysis
6.5 Europe Amyotrophic Lateral Sclerosis Market Segmentation: By Treatment Type
6.5.1 Europe Amyotrophic Lateral Sclerosis Market, By Treatment Type Overview
6.5.2 Europe Amyotrophic Lateral Sclerosis Market Size, By Medications, By Value, 2020H-2030F (USD Million & CAGR)
6.5.3 Europe Amyotrophic Lateral Sclerosis Market Size, By Respiratory Therapy, By Value, 2020H-2030F (USD Million & CAGR)
6.5.4 Europe Amyotrophic Lateral Sclerosis Market Size, By Speech Therapy, By Value, 2020H-2030F (USD Million & CAGR)
6.5.5 Europe Amyotrophic Lateral Sclerosis Market Size, By Physical Therapy, By Value, 2020H-2030F (USD Million & CAGR)
6.5.6 Europe Amyotrophic Lateral Sclerosis Market Size, By Other Treatment Types, By Value, 2020H-2030F (USD Million & CAGR)
6.6 Europe Amyotrophic Lateral Sclerosis Market Segmentation: By Drug
6.6.1 Europe Amyotrophic Lateral Sclerosis Market, By Drug Overview
6.6.2 Europe Amyotrophic Lateral Sclerosis Market Size, By Edaravone, By Value, 2020H-2030F (USD Million & CAGR)
6.6.3 Europe Amyotrophic Lateral Sclerosis Market Size, By Nuedexta, By Value, 2020H-2030F (USD Million & CAGR)
6.6.4 Europe Amyotrophic Lateral Sclerosis Market Size, By Riluzole, By Value, 2020H-2030F (USD Million & CAGR)
6.6.5 Europe Amyotrophic Lateral Sclerosis Market Size, By Other Drugs, By Value, 2020H-2030F (USD Million & CAGR)
6.7 Europe Amyotrophic Lateral Sclerosis Market Segmentation: By Distribution Channel
6.7.1 Europe Amyotrophic Lateral Sclerosis Market, By Distribution Channel Overview
6.7.2 Europe Amyotrophic Lateral Sclerosis Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
6.7.3 Europe Amyotrophic Lateral Sclerosis Market Size, By Retail Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
6.8 Europe Amyotrophic Lateral Sclerosis Market Segmentation: By Country
6.8.1 Europe Amyotrophic Lateral Sclerosis Market, by Country Overview
6.8.2 Russia Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.2.1 Russia Amyotrophic Lateral Sclerosis Market, By Treatment Type
6.8.2.2 Russia Amyotrophic Lateral Sclerosis Market, By Drug
6.8.2.3 Russia Amyotrophic Lateral Sclerosis Market, By Distribution Channel
6.8.3 France Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.3.1 France Amyotrophic Lateral Sclerosis Market, By Treatment Type
6.8.3.2 France Amyotrophic Lateral Sclerosis Market, By Drug
6.8.3.3 France Amyotrophic Lateral Sclerosis Market, By Distribution Channel
6.8.4 United Kingdom Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.4.1 United Kingdom Amyotrophic Lateral Sclerosis Market, By Treatment Type
6.8.4.2 United Kingdom Amyotrophic Lateral Sclerosis Market, By Drug
6.8.4.3 United Kingdom Amyotrophic Lateral Sclerosis Market, By Distribution Channel
6.8.5 Germany Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.5.1 Germany Amyotrophic Lateral Sclerosis Market, By Treatment Type
6.8.5.2 Germany Amyotrophic Lateral Sclerosis Market, By Drug
6.8.5.3 Germany Amyotrophic Lateral Sclerosis Market, By Distribution Channel
6.8.6 Italy Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.6.1 Italy Amyotrophic Lateral Sclerosis Market, By Treatment Type
6.8.6.2 Italy Amyotrophic Lateral Sclerosis Market, By Drug
6.8.6.3 Italy Amyotrophic Lateral Sclerosis Market, By Distribution Channel
6.8.7 Spain Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.7.1 Spain Amyotrophic Lateral Sclerosis Market, By Treatment Type
6.8.7.2 Spain Amyotrophic Lateral Sclerosis Market, By Drug
6.8.7.3 Spain Amyotrophic Lateral Sclerosis Market, By Distribution Channel
6.8.8 Turkey Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.8.1 Turkey Amyotrophic Lateral Sclerosis Market, By Treatment Type
6.8.8.2 Turkey Amyotrophic Lateral Sclerosis Market, By Drug
6.8.8.3 Turkey Amyotrophic Lateral Sclerosis Market, By Distribution Channel
6.8.9 Rest of Europe Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.9.1 Rest of Europe Amyotrophic Lateral Sclerosis Market, By Treatment Type
6.8.9.2 Rest of Europe Amyotrophic Lateral Sclerosis Market, By Drug
6.8.9.3 Rest of Europe Amyotrophic Lateral Sclerosis Market, By Distribution Channel
7. Asia Pacific Amyotrophic Lateral Sclerosis Market: Historic and Forecast
7.1 Asia Pacific Amyotrophic Lateral Sclerosis Market: Snapshot
7.2 Asia Pacific Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, By Value, 2020-2030 (USD Million & CAGR)
7.3 Asia Pacific Amyotrophic Lateral Sclerosis Market: Key Factors
7.4 Asia Pacific Amyotrophic Lateral Sclerosis Market: Segment Analysis
7.5 Asia Pacific Amyotrophic Lateral Sclerosis Market Segmentation: By Treatment Type
7.5.1 Asia Pacific Amyotrophic Lateral Sclerosis Market, By Treatment Type Overview
7.5.2 Asia Pacific Amyotrophic Lateral Sclerosis Market Size, By Medications, By Value, 2020H-2030F (USD Million & CAGR)
7.5.3 Asia Pacific Amyotrophic Lateral Sclerosis Market Size, By Respiratory Therapy, By Value, 2020H-2030F (USD Million & CAGR)
7.5.4 Asia Pacific Amyotrophic Lateral Sclerosis Market Size, By Speech Therapy, By Value, 2020H-2030F (USD Million & CAGR)
7.5.5 Asia Pacific Amyotrophic Lateral Sclerosis Market Size, By Physical Therapy, By Value, 2020H-2030F (USD Million & CAGR)
7.5.6 Asia Pacific Amyotrophic Lateral Sclerosis Market Size, By Other Treatment Types, By Value, 2020H-2030F (USD Million & CAGR)
7.6 Asia Pacific Amyotrophic Lateral Sclerosis Market Segmentation: By Drug
7.6.1 Asia Pacific Amyotrophic Lateral Sclerosis Market, By Drug Overview
7.6.2 Asia Pacific Amyotrophic Lateral Sclerosis Market Size, By Edaravone, By Value, 2020H-2030F (USD Million & CAGR)
7.6.3 Asia Pacific Amyotrophic Lateral Sclerosis Market Size, By Nuedexta, By Value, 2020H-2030F (USD Million & CAGR)
7.6.4 Asia Pacific Amyotrophic Lateral Sclerosis Market Size, By Riluzole, By Value, 2020H-2030F (USD Million & CAGR)
7.6.5 Asia Pacific Amyotrophic Lateral Sclerosis Market Size, By Other Drugs, By Value, 2020H-2030F (USD Million & CAGR)
7.7 Asia Pacific Amyotrophic Lateral Sclerosis Market Segmentation: By Distribution Channel
7.7.1 Asia Pacific Amyotrophic Lateral Sclerosis Market, By Distribution Channel Overview
7.7.2 Asia Pacific Amyotrophic Lateral Sclerosis Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
7.7.3 Asia Pacific Amyotrophic Lateral Sclerosis Market Size, By Retail Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
7.8 Asia Pacific Amyotrophic Lateral Sclerosis Market Segmentation: By Country
7.8.1 Asia Pacific Amyotrophic Lateral Sclerosis Market, by Country Overview
7.8.2 China Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.2.1 China Amyotrophic Lateral Sclerosis Market, By Treatment Type
7.8.2.2 China Amyotrophic Lateral Sclerosis Market, By Drug
7.8.2.3 China Amyotrophic Lateral Sclerosis Market, By Distribution Channel
7.8.3 India Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.3.1 India Amyotrophic Lateral Sclerosis Market, By Treatment Type
7.8.3.2 India Amyotrophic Lateral Sclerosis Market, By Drug
7.8.3.3 India Amyotrophic Lateral Sclerosis Market, By Distribution Channel
7.8.4 South Korea Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.4.1 South Korea Amyotrophic Lateral Sclerosis Market, By Treatment Type
7.8.4.2 South Korea Amyotrophic Lateral Sclerosis Market, By Drug
7.8.4.3 South Korea Amyotrophic Lateral Sclerosis Market, By Distribution Channel
7.8.5 Japan Korea Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.5.1 Japan Amyotrophic Lateral Sclerosis Market, By Treatment Type
7.8.5.2 Japan Amyotrophic Lateral Sclerosis Market, By Drug
7.8.5.3 Japan Amyotrophic Lateral Sclerosis Market, By Distribution Channel
7.8.6 Singapore Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.6.1 Singapore Amyotrophic Lateral Sclerosis Market, By Treatment Type
7.8.6.2 Singapore Amyotrophic Lateral Sclerosis Market, By Drug
7.8.6.3 Singapore Amyotrophic Lateral Sclerosis Market, By Distribution Channel
7.8.7 Indonesia Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.7.1 Indonesia Amyotrophic Lateral Sclerosis Market, By Treatment Type
7.8.7.2 Indonesia Amyotrophic Lateral Sclerosis Market, By Drug
7.8.7.3 Indonesia Amyotrophic Lateral Sclerosis Market, By Distribution Channel
7.8.8 Rest of Asia Pacific Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.8.1 Rest of Asia Pacific Amyotrophic Lateral Sclerosis Market, By Treatment Type
7.8.8.2 Rest of Asia Pacific Amyotrophic Lateral Sclerosis Market, By Drug
7.8.8.3 Rest of Asia Pacific Amyotrophic Lateral Sclerosis Market, By Distribution Channel
7.2 Asia Pacific Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, By Value, 2020-2030 (USD Million & CAGR)
7.3 Asia Pacific Amyotrophic Lateral Sclerosis Market: Key Factors
7.4 Asia Pacific Amyotrophic Lateral Sclerosis Market: Segment Analysis
7.5 Asia Pacific Amyotrophic Lateral Sclerosis Market Segmentation: By Treatment Type
7.5.1 Asia Pacific Amyotrophic Lateral Sclerosis Market, By Treatment Type Overview
7.5.2 Asia Pacific Amyotrophic Lateral Sclerosis Market Size, By Medications, By Value, 2020H-2030F (USD Million & CAGR)
7.5.3 Asia Pacific Amyotrophic Lateral Sclerosis Market Size, By Respiratory Therapy, By Value, 2020H-2030F (USD Million & CAGR)
7.5.4 Asia Pacific Amyotrophic Lateral Sclerosis Market Size, By Speech Therapy, By Value, 2020H-2030F (USD Million & CAGR)
7.5.5 Asia Pacific Amyotrophic Lateral Sclerosis Market Size, By Physical Therapy, By Value, 2020H-2030F (USD Million & CAGR)
7.5.6 Asia Pacific Amyotrophic Lateral Sclerosis Market Size, By Other Treatment Types, By Value, 2020H-2030F (USD Million & CAGR)
7.6 Asia Pacific Amyotrophic Lateral Sclerosis Market Segmentation: By Drug
7.6.1 Asia Pacific Amyotrophic Lateral Sclerosis Market, By Drug Overview
7.6.2 Asia Pacific Amyotrophic Lateral Sclerosis Market Size, By Edaravone, By Value, 2020H-2030F (USD Million & CAGR)
7.6.3 Asia Pacific Amyotrophic Lateral Sclerosis Market Size, By Nuedexta, By Value, 2020H-2030F (USD Million & CAGR)
7.6.4 Asia Pacific Amyotrophic Lateral Sclerosis Market Size, By Riluzole, By Value, 2020H-2030F (USD Million & CAGR)
7.6.5 Asia Pacific Amyotrophic Lateral Sclerosis Market Size, By Other Drugs, By Value, 2020H-2030F (USD Million & CAGR)
7.7 Asia Pacific Amyotrophic Lateral Sclerosis Market Segmentation: By Distribution Channel
7.7.1 Asia Pacific Amyotrophic Lateral Sclerosis Market, By Distribution Channel Overview
7.7.2 Asia Pacific Amyotrophic Lateral Sclerosis Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
7.7.3 Asia Pacific Amyotrophic Lateral Sclerosis Market Size, By Retail Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
7.8 Asia Pacific Amyotrophic Lateral Sclerosis Market Segmentation: By Country
7.8.1 Asia Pacific Amyotrophic Lateral Sclerosis Market, by Country Overview
7.8.2 China Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.2.1 China Amyotrophic Lateral Sclerosis Market, By Treatment Type
7.8.2.2 China Amyotrophic Lateral Sclerosis Market, By Drug
7.8.2.3 China Amyotrophic Lateral Sclerosis Market, By Distribution Channel
7.8.3 India Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.3.1 India Amyotrophic Lateral Sclerosis Market, By Treatment Type
7.8.3.2 India Amyotrophic Lateral Sclerosis Market, By Drug
7.8.3.3 India Amyotrophic Lateral Sclerosis Market, By Distribution Channel
7.8.4 South Korea Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.4.1 South Korea Amyotrophic Lateral Sclerosis Market, By Treatment Type
7.8.4.2 South Korea Amyotrophic Lateral Sclerosis Market, By Drug
7.8.4.3 South Korea Amyotrophic Lateral Sclerosis Market, By Distribution Channel
7.8.5 Japan Korea Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.5.1 Japan Amyotrophic Lateral Sclerosis Market, By Treatment Type
7.8.5.2 Japan Amyotrophic Lateral Sclerosis Market, By Drug
7.8.5.3 Japan Amyotrophic Lateral Sclerosis Market, By Distribution Channel
7.8.6 Singapore Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.6.1 Singapore Amyotrophic Lateral Sclerosis Market, By Treatment Type
7.8.6.2 Singapore Amyotrophic Lateral Sclerosis Market, By Drug
7.8.6.3 Singapore Amyotrophic Lateral Sclerosis Market, By Distribution Channel
7.8.7 Indonesia Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.7.1 Indonesia Amyotrophic Lateral Sclerosis Market, By Treatment Type
7.8.7.2 Indonesia Amyotrophic Lateral Sclerosis Market, By Drug
7.8.7.3 Indonesia Amyotrophic Lateral Sclerosis Market, By Distribution Channel
7.8.8 Rest of Asia Pacific Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.8.1 Rest of Asia Pacific Amyotrophic Lateral Sclerosis Market, By Treatment Type
7.8.8.2 Rest of Asia Pacific Amyotrophic Lateral Sclerosis Market, By Drug
7.8.8.3 Rest of Asia Pacific Amyotrophic Lateral Sclerosis Market, By Distribution Channel
8. Middle East & Africa Amyotrophic Lateral Sclerosis Market: Historic and Forecast
8.1 Middle East & Africa Amyotrophic Lateral Sclerosis Market: Snapshot
8.2 Middle East & Africa Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, By Value, 2020-2030 (USD Million & CAGR)
8.3 Middle East & Africa Amyotrophic Lateral Sclerosis Market: Key Factors
8.4 Middle East and Africa Amyotrophic Lateral Sclerosis Market: Segment Analysis
8.5 Middle East & Africa Amyotrophic Lateral Sclerosis Market Segmentation: By Treatment Type
8.5.1 Middle East & Africa Amyotrophic Lateral Sclerosis Market, By Treatment Type Overview
8.5.2 Middle East & Africa Amyotrophic Lateral Sclerosis Market Size, By Medications, By Value, 2020H-2030F (USD Million & CAGR)
8.5.3 Middle East & Africa Amyotrophic Lateral Sclerosis Market Size, By Respiratory Therapy, By Value, 2020H-2030F (USD Million & CAGR)
8.5.4 Middle East & Africa Amyotrophic Lateral Sclerosis Market Size, By Speech Therapy, By Value, 2020H-2030F (USD Million & CAGR)
8.5.5 Middle East & Africa Amyotrophic Lateral Sclerosis Market Size, By Physical Therapy, By Value, 2020H-2030F (USD Million & CAGR)
8.5.6 Middle East & Africa Amyotrophic Lateral Sclerosis Market Size, By Other Treatment Types, By Value, 2020H-2030F (USD Million & CAGR)
8.6 Middle East & Africa Amyotrophic Lateral Sclerosis Market Segmentation: By Drug
8.6.1 Middle East & Africa Amyotrophic Lateral Sclerosis Market, By Drug Overview
8.6.2 Middle East & Africa Amyotrophic Lateral Sclerosis Market Size, By Edaravone, By Value, 2020H-2030F (USD Million & CAGR)
8.6.3 Middle East & Africa Amyotrophic Lateral Sclerosis Market Size, By Nuedexta, By Value, 2020H-2030F (USD Million & CAGR)
8.6.4 Middle East & Africa Amyotrophic Lateral Sclerosis Market Size, By Riluzole, By Value, 2020H-2030F (USD Million & CAGR)
8.6.5 Middle East & Africa Amyotrophic Lateral Sclerosis Market Size, By Other Drugs, By Value, 2020H-2030F (USD Million & CAGR)
8.7 Middle East & Africa Amyotrophic Lateral Sclerosis Market Segmentation: By Distribution Channel
8.7.1 Middle East & Africa Amyotrophic Lateral Sclerosis Market, By Distribution Channel Overview
8.7.2 Middle East & Africa Amyotrophic Lateral Sclerosis Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
8.7.3 Middle East & Africa Amyotrophic Lateral Sclerosis Market Size, By Retail Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
8.8 Middle East & Africa Amyotrophic Lateral Sclerosis Market Segmentation: By Country
8.8.1 Middle East & Africa Amyotrophic Lateral Sclerosis Market, by Country Overview
8.8.2 GCC Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.8.2.1 GCC Amyotrophic Lateral Sclerosis Market, By Treatment Type
8.8.2.2 GCC Amyotrophic Lateral Sclerosis Market, By Drug
8.8.2.3 GCC Amyotrophic Lateral Sclerosis Market, By Distribution Channel
8.8.3 Israel Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.8.3.1 Israel Amyotrophic Lateral Sclerosis Market, By Treatment Type
8.8.3.2 Israel Amyotrophic Lateral Sclerosis Market, By Drug
8.8.3.3 Israel Amyotrophic Lateral Sclerosis Market, By Distribution Channel
8.8.4 South Africa Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.8.4.1 South Africa Amyotrophic Lateral Sclerosis Market, By Treatment Type
8.8.4.2 South Africa Amyotrophic Lateral Sclerosis Market, By Drug
8.8.4.3 South Africa Amyotrophic Lateral Sclerosis Market, By Distribution Channel
8.8.5 Rest of Middle East and Africa Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.8.5.1 Rest of Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Treatment Type
8.8.5.2 Rest of Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Drug
8.8.5.3 Rest of Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Distribution Channel
8.2 Middle East & Africa Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, By Value, 2020-2030 (USD Million & CAGR)
8.3 Middle East & Africa Amyotrophic Lateral Sclerosis Market: Key Factors
8.4 Middle East and Africa Amyotrophic Lateral Sclerosis Market: Segment Analysis
8.5 Middle East & Africa Amyotrophic Lateral Sclerosis Market Segmentation: By Treatment Type
8.5.1 Middle East & Africa Amyotrophic Lateral Sclerosis Market, By Treatment Type Overview
8.5.2 Middle East & Africa Amyotrophic Lateral Sclerosis Market Size, By Medications, By Value, 2020H-2030F (USD Million & CAGR)
8.5.3 Middle East & Africa Amyotrophic Lateral Sclerosis Market Size, By Respiratory Therapy, By Value, 2020H-2030F (USD Million & CAGR)
8.5.4 Middle East & Africa Amyotrophic Lateral Sclerosis Market Size, By Speech Therapy, By Value, 2020H-2030F (USD Million & CAGR)
8.5.5 Middle East & Africa Amyotrophic Lateral Sclerosis Market Size, By Physical Therapy, By Value, 2020H-2030F (USD Million & CAGR)
8.5.6 Middle East & Africa Amyotrophic Lateral Sclerosis Market Size, By Other Treatment Types, By Value, 2020H-2030F (USD Million & CAGR)
8.6 Middle East & Africa Amyotrophic Lateral Sclerosis Market Segmentation: By Drug
8.6.1 Middle East & Africa Amyotrophic Lateral Sclerosis Market, By Drug Overview
8.6.2 Middle East & Africa Amyotrophic Lateral Sclerosis Market Size, By Edaravone, By Value, 2020H-2030F (USD Million & CAGR)
8.6.3 Middle East & Africa Amyotrophic Lateral Sclerosis Market Size, By Nuedexta, By Value, 2020H-2030F (USD Million & CAGR)
8.6.4 Middle East & Africa Amyotrophic Lateral Sclerosis Market Size, By Riluzole, By Value, 2020H-2030F (USD Million & CAGR)
8.6.5 Middle East & Africa Amyotrophic Lateral Sclerosis Market Size, By Other Drugs, By Value, 2020H-2030F (USD Million & CAGR)
8.7 Middle East & Africa Amyotrophic Lateral Sclerosis Market Segmentation: By Distribution Channel
8.7.1 Middle East & Africa Amyotrophic Lateral Sclerosis Market, By Distribution Channel Overview
8.7.2 Middle East & Africa Amyotrophic Lateral Sclerosis Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
8.7.3 Middle East & Africa Amyotrophic Lateral Sclerosis Market Size, By Retail Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
8.8 Middle East & Africa Amyotrophic Lateral Sclerosis Market Segmentation: By Country
8.8.1 Middle East & Africa Amyotrophic Lateral Sclerosis Market, by Country Overview
8.8.2 GCC Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.8.2.1 GCC Amyotrophic Lateral Sclerosis Market, By Treatment Type
8.8.2.2 GCC Amyotrophic Lateral Sclerosis Market, By Drug
8.8.2.3 GCC Amyotrophic Lateral Sclerosis Market, By Distribution Channel
8.8.3 Israel Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.8.3.1 Israel Amyotrophic Lateral Sclerosis Market, By Treatment Type
8.8.3.2 Israel Amyotrophic Lateral Sclerosis Market, By Drug
8.8.3.3 Israel Amyotrophic Lateral Sclerosis Market, By Distribution Channel
8.8.4 South Africa Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.8.4.1 South Africa Amyotrophic Lateral Sclerosis Market, By Treatment Type
8.8.4.2 South Africa Amyotrophic Lateral Sclerosis Market, By Drug
8.8.4.3 South Africa Amyotrophic Lateral Sclerosis Market, By Distribution Channel
8.8.5 Rest of Middle East and Africa Amyotrophic Lateral Sclerosis Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.8.5.1 Rest of Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Treatment Type
8.8.5.2 Rest of Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Drug
8.8.5.3 Rest of Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Distribution Channel
9. Market Dynamics
9.1 Impact assessment of Market Dynamics on Amyotrophic Lateral Sclerosis Market
9.2 Drivers
9.3 Restraints
9.4 Trends
9.2 Drivers
9.3 Restraints
9.4 Trends
10. Ecosystem Analysis
10.1 Porter Analysis
11. Competitive Positioning
11.1 Companies’ Competitive Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Amyotrophic Lateral Sclerosis Market
11.4 Company Profiles
11.4.1 Biohaven Pharmaceutical
11.4.2 Ionis Pharmaceuticals, Inc.
11.4.3 Sun Pharmaceutical
11.4.4 BrainStorm Therapeutics
11.4.5 F.Hoffmann-La Roche AG
11.4.6 Mitsubishi Tanabe Pharma Corporation
11.4.7 Biogen Inc.
11.4.8 Corestem
11.4.9 Otsuka Pharmaceutical Co., Ltd.
11.4.10 AB Science
11.4.11 Other Leading Companies
11.2 Market Position Matrix
11.3 Market Share Analysis of Amyotrophic Lateral Sclerosis Market
11.4 Company Profiles
11.4.1 Biohaven Pharmaceutical
11.4.2 Ionis Pharmaceuticals, Inc.
11.4.3 Sun Pharmaceutical
11.4.4 BrainStorm Therapeutics
11.4.5 F.Hoffmann-La Roche AG
11.4.6 Mitsubishi Tanabe Pharma Corporation
11.4.7 Biogen Inc.
11.4.8 Corestem
11.4.9 Otsuka Pharmaceutical Co., Ltd.
11.4.10 AB Science
11.4.11 Other Leading Companies
List of Figures
Figure 1: Amyotrophic Lateral Sclerosis Market, Comparison of Leading Countries, 2023 (%)
Figure 2: Amyotrophic Lateral Sclerosis Market, Comparison of Leading Countries, 2030 (%)
Figure 3: Amyotrophic Lateral Sclerosis Market Type Matrix
Figure 4: Amyotrophic Lateral Sclerosis Market Demand Analysis
Figure 5: Global Amyotrophic Lateral Sclerosis Market Size, By Value, 2020-2023 (USD Million)
Figure 6: Global Amyotrophic Lateral Sclerosis Market Size, By Value, 2024-2030 (USD Million)
Figure 7: Global Amyotrophic Lateral Sclerosis Market Share, By Drug, 2023 (%)
Figure 8: Global Amyotrophic Lateral Sclerosis Market CAGR, 2020-2023 (%)
Figure 9: Global Amyotrophic Lateral Sclerosis Market CAGR, 2025-2030 (%)
Figure 10: Global Amyotrophic Lateral Sclerosis Market CAGR (%), By Region, 2020-2023, 2025-2030
Figure 11: Market Attractiveness Analysis of Global Amyotrophic Lateral Sclerosis Market, By Treatment Type (2025-2030)
Figure 12: Global Amyotrophic Lateral Sclerosis Market Size, By Medications, By Value, 2020H-2030F (USD Million & CAGR)
Figure 13: Global Amyotrophic Lateral Sclerosis Market Absolute Opportunity, By Medications, 2020-2030 (USD Million)
Figure 14: Global Amyotrophic Lateral Sclerosis Market Size, By Respiratory Therapy, By Value, 2020H-2030F (USD Million & CAGR)
Figure 15: Global Amyotrophic Lateral Sclerosis Market Absolute Opportunity, By Respiratory Therapy, 2020-2030 (USD Million)
Figure 16: Global Amyotrophic Lateral Sclerosis Market Size, By Speech Therapy, By Value, 2020H-2030F (USD Million & CAGR)
Figure 17: Global Amyotrophic Lateral Sclerosis Market Absolute Opportunity, By Speech Therapy, 2020-2030 (USD Million)
Figure 18: Global Amyotrophic Lateral Sclerosis Market Size, By Physical Therapy, By Value, 2020H-2030F (USD Million & CAGR)
Figure 19: Global Amyotrophic Lateral Sclerosis Market Absolute Opportunity, By Physical Therapy, 2020-2030 (USD Million)
Figure 20: Global Amyotrophic Lateral Sclerosis Market Size, By Other Treatment Types, By Value, 2020H-2030F (USD Million & CAGR)
Figure 21: Global Amyotrophic Lateral Sclerosis Market Absolute Opportunity, By Other Treatment Types, 2020-2030 (USD Million)
Figure 22: Market Attractiveness Analysis of Global Amyotrophic Lateral Sclerosis Market, By Drug (2025-2030)
Figure 23: Global Amyotrophic Lateral Sclerosis Market Size, By Edaravone, By Value, 2020H-2030F (USD Million & CAGR)
Figure 24: Global Amyotrophic Lateral Sclerosis Market Absolute Opportunity, By Edaravone, 2020-2030 (USD Million)
Figure 25: Global Amyotrophic Lateral Sclerosis Market Size, By Nuedexta, By Value, 2020H-2030F (USD Million & CAGR)
Figure 26: Global Amyotrophic Lateral Sclerosis Market Absolute Opportunity, By Nuedexta, 2020-2030 (USD Million)
Figure 27: Global Amyotrophic Lateral Sclerosis Market Size, By Riluzole, By Value, 2020H-2030F (USD Million & CAGR)
Figure 28: Global Amyotrophic Lateral Sclerosis Market Absolute Opportunity, By Riluzole, 2020-2030 (USD Million)
Figure 29: Global Amyotrophic Lateral Sclerosis Market Size, By Other Drugs, By Value, 2020H-2030F (USD Million & CAGR)
Figure 30: Global Amyotrophic Lateral Sclerosis Market Absolute Opportunity, By Other Drugs, 2020-2030 (USD Million)
Figure 31: Market Attractiveness Analysis of Global Amyotrophic Lateral Sclerosis Market, By Distribution Channel (2025-2030)
Figure 32: Global Amyotrophic Lateral Sclerosis Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
Figure 33: Global Amyotrophic Lateral Sclerosis Market Absolute Opportunity, By Online Pharmacies, 2020-2030 (USD Million)
Figure 34: Global Amyotrophic Lateral Sclerosis Market Size, By Retail Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
Figure 35: Global Amyotrophic Lateral Sclerosis Market Absolute Opportunity, By Retail Pharmacies, 2020-2030 (USD Million)
Figure 36: Americas Amyotrophic Lateral Sclerosis Market Size, By Value, 2020H-2030F (USD Million)
Figure 37: Americas Amyotrophic Lateral Sclerosis Market Share, By Drug, 2023 (%)
Figure 38: Americas Amyotrophic Lateral Sclerosis Market Share, By New Product Launches, 2023 (%)
Figure 39: Americas Amyotrophic Lateral Sclerosis Market Share, By Company, 2023 (%)
Figure 40: Americas Amyotrophic Lateral Sclerosis Market CAGR (%), By Region, 2020-2023, 2025-2030
Figure 41: Americas Amyotrophic Lateral Sclerosis Market, By Medications, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 42: Americas Amyotrophic Lateral Sclerosis Market, By Respiratory Therapy, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 43: Americas Amyotrophic Lateral Sclerosis Market, By Speech Therapy, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 44: Americas Amyotrophic Lateral Sclerosis Market, By Physical Therapy, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 45: Americas Amyotrophic Lateral Sclerosis Market, By Other Treatment Types, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 46: Figure 46: Americas Amyotrophic Lateral Sclerosis Market, By Edaravone, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 47: Americas Amyotrophic Lateral Sclerosis Market, By Nuedexta, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 48: Americas Amyotrophic Lateral Sclerosis Market, By Speech Therapy, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 49: Americas Amyotrophic Lateral Sclerosis Market, By Other Drugs, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 50: Americas Amyotrophic Lateral Sclerosis Market, By Online Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 51: Americas Amyotrophic Lateral Sclerosis Market, By Retail Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 52: United States Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 53: United States Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 54: United States Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 55: United States Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 56: United States Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 57: Canada Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 58: Canada Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 59: Canada Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 60: Canada Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 61: Canada Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 62: Brazil Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 63: Brazil Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 64: Brazil Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 65: Brazil Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 66: Brazil Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 67: Mexico Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 68: Mexico Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 69: Mexico Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 70: Mexico Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 71: Mexico Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 72: Rest of Americas Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 73: Rest of Americas Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 74: Rest of Americas Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 75: Rest of Americas Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 76: Rest of Americas Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 77: Europe Amyotrophic Lateral Sclerosis Market Size, By Value, 2020H-2030F (USD Million)
Figure 78: Europe Amyotrophic Lateral Sclerosis Market Share, By Drug, 2023 (%)
Figure 79: Europe Amyotrophic Lateral Sclerosis Market Share, By New Product Launches, 2023 (%)
Figure 80: Europe Amyotrophic Lateral Sclerosis Market Share, By Company, 2023 (%)
Figure 81: Europe Amyotrophic Lateral Sclerosis Market CAGR (%), By Region, 2020-2023, 2025-2030
Figure 82: Europe Amyotrophic Lateral Sclerosis Market, By Medications, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 83: Europe Amyotrophic Lateral Sclerosis Market, By Respiratory Therapy, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 84: Europe Amyotrophic Lateral Sclerosis Market, By Speech Therapy, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 85: Europe Amyotrophic Lateral Sclerosis Market, By Physical Therapy, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 86: Europe Amyotrophic Lateral Sclerosis Market, By Other Treatment Types, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 87: Europe Amyotrophic Lateral Sclerosis Market, By Edaravone, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 88: Europe Amyotrophic Lateral Sclerosis Market, By Nuedexta, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 89: Europe Amyotrophic Lateral Sclerosis Market, By Riluzole, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 90: Europe Amyotrophic Lateral Sclerosis Market, By Other Drugs, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 91: Europe Amyotrophic Lateral Sclerosis Market, By Online Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 92: Europe Amyotrophic Lateral Sclerosis Market, By Retail Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 93: Russia Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 94: Russia Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 95: Russia Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 96: Russia Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 97: Russia Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 98: France Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 99: France Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 100: France Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 101: France Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 102: France Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 103: United Kingdom Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 104: United Kingdom Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 105: United Kingdom Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 106: United Kingdom Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 107: United Kingdom Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 108: Germany Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 109: Germany Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 110: Germany Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 111: Germany Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 112: Germany Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 113: Italy Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 114: Italy Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 115: Italy Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 116: Italy Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 117: Italy Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 118: Spain Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 119: Spain Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 120: Spain Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 121: Spain Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 122: Spain Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 123: Turkey Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 124: Turkey Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 125: Turkey Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 126: Turkey Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 127: Turkey Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 128: Rest of Europe Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 129: Rest of Europe Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 130: Rest of Europe Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 131: Rest of Europe Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 132: Rest of Europe Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 133: Asia Pacific Amyotrophic Lateral Sclerosis Market Size, By Value, 2020H-2030F (USD Million)
Figure 134: Asia Pacific Amyotrophic Lateral Sclerosis Market Share, By Drug, 2023 (%)
Figure 135: Asia Pacific Amyotrophic Lateral Sclerosis Market Share, By New Product Launches, 2023 (%)
Figure 136: Asia Pacific Amyotrophic Lateral Sclerosis Market Share, By Company, 2023 (%)
Figure 137: Asia Pacific Amyotrophic Lateral Sclerosis Market CAGR (%), By Region, 2020-2023, 2025-2030
Figure 138: Asia Pacific Amyotrophic Lateral Sclerosis Market, By Medications, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 139: Asia Pacific Amyotrophic Lateral Sclerosis Market, By Respiratory Therapy, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 140: Asia Pacific Amyotrophic Lateral Sclerosis Market, By Speech Therapy, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 141: Asia Pacific Amyotrophic Lateral Sclerosis Market, By Physical Therapy, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 142: Asia Pacific Amyotrophic Lateral Sclerosis Market, By Other Treatment Types, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 143: Asia Pacific Amyotrophic Lateral Sclerosis Market, By Edaravone, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 144: Asia Pacific Amyotrophic Lateral Sclerosis Market, By Nuedexta, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 145: Asia Pacific Amyotrophic Lateral Sclerosis Market, By Riluzole, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 146: Asia Pacific Amyotrophic Lateral Sclerosis Market, By Other Drugs, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 147: Asia Pacific Amyotrophic Lateral Sclerosis Market, By Online Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 148: Asia Pacific Amyotrophic Lateral Sclerosis Market, By Retail Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 149: China Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 150: China Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 151: China Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 152: China Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 153: China Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 154: India Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 155: India Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 156: India Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 157: India Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 158: India Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 159: South Korea Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 160: South Korea Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 161: South Korea Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 162: South Korea Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 163: South Korea Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 164: Japan Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 165: Japan Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 166: Japan Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 167: Japan Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 168: Japan Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 169: Singapore Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 170: Singapore Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 171: Singapore Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 172: Singapore Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 173: Singapore Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 174: Indonesia Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 175: Indonesia Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 176: Indonesia Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 177: Indonesia Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 178: Indonesia Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 179: Rest of Asia Pacific Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 180: Rest of Asia Pacific Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 181: Rest of Asia Pacific Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 182: Rest of Asia Pacific Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 183: Rest of Asia Pacific Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 184: Middle East and Africa Amyotrophic Lateral Sclerosis Market Size, By Value, 2020H-2030F (USD Million)
Figure 185: Middle East and Africa Amyotrophic Lateral Sclerosis Market Share, By Drug, 2023 (%)
Figure 186: Middle East and Africa Amyotrophic Lateral Sclerosis Market Share, By New Product Launches, 2023 (%)
Figure 187: Middle East and Africa Amyotrophic Lateral Sclerosis Market Share, By Company, 2023 (%)
Figure 188: Middle East and Africa Amyotrophic Lateral Sclerosis Market CAGR (%), By Region, 2020-2023, 2025-2030
Figure 189: Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Medications, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 190: Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Respiratory Therapy, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 191: Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Speech Therapy, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 192: Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Physical Therapy, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 193: Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Other Treatment Types, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 194: Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Edaravone, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 195: Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Nuedexta, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 196: Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Riluzole, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 197: Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Other Drugs, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 198: Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Online Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 199: Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Retail Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 200: GCC Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 201: GCC Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 202: GCC Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 203: GCC Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 204: GCC Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 205: Israel Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 206: Israel Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 207: Israel Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 208: Israel Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 209: Israel Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 210: South Africa Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 211: South Africa Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 212: South Africa Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 213: South Africa Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 214: South Africa Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 215: Rest of Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 216: Rest of Middle East and Africa Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 217: Rest of Middle East and Africa Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 218: Rest of Middle East and Africa Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 219: Rest of Middle East and Africa Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 220: Market Share of Prominent Companies of Global Amyotrophic Lateral Sclerosis Market, 2023 (%)
Figure 2: Amyotrophic Lateral Sclerosis Market, Comparison of Leading Countries, 2030 (%)
Figure 3: Amyotrophic Lateral Sclerosis Market Type Matrix
Figure 4: Amyotrophic Lateral Sclerosis Market Demand Analysis
Figure 5: Global Amyotrophic Lateral Sclerosis Market Size, By Value, 2020-2023 (USD Million)
Figure 6: Global Amyotrophic Lateral Sclerosis Market Size, By Value, 2024-2030 (USD Million)
Figure 7: Global Amyotrophic Lateral Sclerosis Market Share, By Drug, 2023 (%)
Figure 8: Global Amyotrophic Lateral Sclerosis Market CAGR, 2020-2023 (%)
Figure 9: Global Amyotrophic Lateral Sclerosis Market CAGR, 2025-2030 (%)
Figure 10: Global Amyotrophic Lateral Sclerosis Market CAGR (%), By Region, 2020-2023, 2025-2030
Figure 11: Market Attractiveness Analysis of Global Amyotrophic Lateral Sclerosis Market, By Treatment Type (2025-2030)
Figure 12: Global Amyotrophic Lateral Sclerosis Market Size, By Medications, By Value, 2020H-2030F (USD Million & CAGR)
Figure 13: Global Amyotrophic Lateral Sclerosis Market Absolute Opportunity, By Medications, 2020-2030 (USD Million)
Figure 14: Global Amyotrophic Lateral Sclerosis Market Size, By Respiratory Therapy, By Value, 2020H-2030F (USD Million & CAGR)
Figure 15: Global Amyotrophic Lateral Sclerosis Market Absolute Opportunity, By Respiratory Therapy, 2020-2030 (USD Million)
Figure 16: Global Amyotrophic Lateral Sclerosis Market Size, By Speech Therapy, By Value, 2020H-2030F (USD Million & CAGR)
Figure 17: Global Amyotrophic Lateral Sclerosis Market Absolute Opportunity, By Speech Therapy, 2020-2030 (USD Million)
Figure 18: Global Amyotrophic Lateral Sclerosis Market Size, By Physical Therapy, By Value, 2020H-2030F (USD Million & CAGR)
Figure 19: Global Amyotrophic Lateral Sclerosis Market Absolute Opportunity, By Physical Therapy, 2020-2030 (USD Million)
Figure 20: Global Amyotrophic Lateral Sclerosis Market Size, By Other Treatment Types, By Value, 2020H-2030F (USD Million & CAGR)
Figure 21: Global Amyotrophic Lateral Sclerosis Market Absolute Opportunity, By Other Treatment Types, 2020-2030 (USD Million)
Figure 22: Market Attractiveness Analysis of Global Amyotrophic Lateral Sclerosis Market, By Drug (2025-2030)
Figure 23: Global Amyotrophic Lateral Sclerosis Market Size, By Edaravone, By Value, 2020H-2030F (USD Million & CAGR)
Figure 24: Global Amyotrophic Lateral Sclerosis Market Absolute Opportunity, By Edaravone, 2020-2030 (USD Million)
Figure 25: Global Amyotrophic Lateral Sclerosis Market Size, By Nuedexta, By Value, 2020H-2030F (USD Million & CAGR)
Figure 26: Global Amyotrophic Lateral Sclerosis Market Absolute Opportunity, By Nuedexta, 2020-2030 (USD Million)
Figure 27: Global Amyotrophic Lateral Sclerosis Market Size, By Riluzole, By Value, 2020H-2030F (USD Million & CAGR)
Figure 28: Global Amyotrophic Lateral Sclerosis Market Absolute Opportunity, By Riluzole, 2020-2030 (USD Million)
Figure 29: Global Amyotrophic Lateral Sclerosis Market Size, By Other Drugs, By Value, 2020H-2030F (USD Million & CAGR)
Figure 30: Global Amyotrophic Lateral Sclerosis Market Absolute Opportunity, By Other Drugs, 2020-2030 (USD Million)
Figure 31: Market Attractiveness Analysis of Global Amyotrophic Lateral Sclerosis Market, By Distribution Channel (2025-2030)
Figure 32: Global Amyotrophic Lateral Sclerosis Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
Figure 33: Global Amyotrophic Lateral Sclerosis Market Absolute Opportunity, By Online Pharmacies, 2020-2030 (USD Million)
Figure 34: Global Amyotrophic Lateral Sclerosis Market Size, By Retail Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
Figure 35: Global Amyotrophic Lateral Sclerosis Market Absolute Opportunity, By Retail Pharmacies, 2020-2030 (USD Million)
Figure 36: Americas Amyotrophic Lateral Sclerosis Market Size, By Value, 2020H-2030F (USD Million)
Figure 37: Americas Amyotrophic Lateral Sclerosis Market Share, By Drug, 2023 (%)
Figure 38: Americas Amyotrophic Lateral Sclerosis Market Share, By New Product Launches, 2023 (%)
Figure 39: Americas Amyotrophic Lateral Sclerosis Market Share, By Company, 2023 (%)
Figure 40: Americas Amyotrophic Lateral Sclerosis Market CAGR (%), By Region, 2020-2023, 2025-2030
Figure 41: Americas Amyotrophic Lateral Sclerosis Market, By Medications, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 42: Americas Amyotrophic Lateral Sclerosis Market, By Respiratory Therapy, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 43: Americas Amyotrophic Lateral Sclerosis Market, By Speech Therapy, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 44: Americas Amyotrophic Lateral Sclerosis Market, By Physical Therapy, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 45: Americas Amyotrophic Lateral Sclerosis Market, By Other Treatment Types, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 46: Figure 46: Americas Amyotrophic Lateral Sclerosis Market, By Edaravone, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 47: Americas Amyotrophic Lateral Sclerosis Market, By Nuedexta, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 48: Americas Amyotrophic Lateral Sclerosis Market, By Speech Therapy, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 49: Americas Amyotrophic Lateral Sclerosis Market, By Other Drugs, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 50: Americas Amyotrophic Lateral Sclerosis Market, By Online Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 51: Americas Amyotrophic Lateral Sclerosis Market, By Retail Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 52: United States Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 53: United States Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 54: United States Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 55: United States Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 56: United States Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 57: Canada Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 58: Canada Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 59: Canada Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 60: Canada Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 61: Canada Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 62: Brazil Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 63: Brazil Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 64: Brazil Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 65: Brazil Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 66: Brazil Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 67: Mexico Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 68: Mexico Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 69: Mexico Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 70: Mexico Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 71: Mexico Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 72: Rest of Americas Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 73: Rest of Americas Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 74: Rest of Americas Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 75: Rest of Americas Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 76: Rest of Americas Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 77: Europe Amyotrophic Lateral Sclerosis Market Size, By Value, 2020H-2030F (USD Million)
Figure 78: Europe Amyotrophic Lateral Sclerosis Market Share, By Drug, 2023 (%)
Figure 79: Europe Amyotrophic Lateral Sclerosis Market Share, By New Product Launches, 2023 (%)
Figure 80: Europe Amyotrophic Lateral Sclerosis Market Share, By Company, 2023 (%)
Figure 81: Europe Amyotrophic Lateral Sclerosis Market CAGR (%), By Region, 2020-2023, 2025-2030
Figure 82: Europe Amyotrophic Lateral Sclerosis Market, By Medications, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 83: Europe Amyotrophic Lateral Sclerosis Market, By Respiratory Therapy, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 84: Europe Amyotrophic Lateral Sclerosis Market, By Speech Therapy, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 85: Europe Amyotrophic Lateral Sclerosis Market, By Physical Therapy, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 86: Europe Amyotrophic Lateral Sclerosis Market, By Other Treatment Types, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 87: Europe Amyotrophic Lateral Sclerosis Market, By Edaravone, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 88: Europe Amyotrophic Lateral Sclerosis Market, By Nuedexta, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 89: Europe Amyotrophic Lateral Sclerosis Market, By Riluzole, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 90: Europe Amyotrophic Lateral Sclerosis Market, By Other Drugs, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 91: Europe Amyotrophic Lateral Sclerosis Market, By Online Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 92: Europe Amyotrophic Lateral Sclerosis Market, By Retail Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 93: Russia Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 94: Russia Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 95: Russia Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 96: Russia Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 97: Russia Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 98: France Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 99: France Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 100: France Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 101: France Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 102: France Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 103: United Kingdom Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 104: United Kingdom Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 105: United Kingdom Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 106: United Kingdom Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 107: United Kingdom Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 108: Germany Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 109: Germany Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 110: Germany Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 111: Germany Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 112: Germany Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 113: Italy Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 114: Italy Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 115: Italy Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 116: Italy Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 117: Italy Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 118: Spain Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 119: Spain Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 120: Spain Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 121: Spain Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 122: Spain Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 123: Turkey Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 124: Turkey Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 125: Turkey Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 126: Turkey Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 127: Turkey Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 128: Rest of Europe Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 129: Rest of Europe Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 130: Rest of Europe Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 131: Rest of Europe Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 132: Rest of Europe Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 133: Asia Pacific Amyotrophic Lateral Sclerosis Market Size, By Value, 2020H-2030F (USD Million)
Figure 134: Asia Pacific Amyotrophic Lateral Sclerosis Market Share, By Drug, 2023 (%)
Figure 135: Asia Pacific Amyotrophic Lateral Sclerosis Market Share, By New Product Launches, 2023 (%)
Figure 136: Asia Pacific Amyotrophic Lateral Sclerosis Market Share, By Company, 2023 (%)
Figure 137: Asia Pacific Amyotrophic Lateral Sclerosis Market CAGR (%), By Region, 2020-2023, 2025-2030
Figure 138: Asia Pacific Amyotrophic Lateral Sclerosis Market, By Medications, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 139: Asia Pacific Amyotrophic Lateral Sclerosis Market, By Respiratory Therapy, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 140: Asia Pacific Amyotrophic Lateral Sclerosis Market, By Speech Therapy, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 141: Asia Pacific Amyotrophic Lateral Sclerosis Market, By Physical Therapy, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 142: Asia Pacific Amyotrophic Lateral Sclerosis Market, By Other Treatment Types, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 143: Asia Pacific Amyotrophic Lateral Sclerosis Market, By Edaravone, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 144: Asia Pacific Amyotrophic Lateral Sclerosis Market, By Nuedexta, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 145: Asia Pacific Amyotrophic Lateral Sclerosis Market, By Riluzole, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 146: Asia Pacific Amyotrophic Lateral Sclerosis Market, By Other Drugs, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 147: Asia Pacific Amyotrophic Lateral Sclerosis Market, By Online Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 148: Asia Pacific Amyotrophic Lateral Sclerosis Market, By Retail Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 149: China Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 150: China Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 151: China Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 152: China Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 153: China Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 154: India Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 155: India Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 156: India Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 157: India Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 158: India Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 159: South Korea Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 160: South Korea Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 161: South Korea Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 162: South Korea Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 163: South Korea Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 164: Japan Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 165: Japan Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 166: Japan Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 167: Japan Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 168: Japan Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 169: Singapore Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 170: Singapore Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 171: Singapore Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 172: Singapore Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 173: Singapore Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 174: Indonesia Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 175: Indonesia Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 176: Indonesia Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 177: Indonesia Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 178: Indonesia Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 179: Rest of Asia Pacific Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 180: Rest of Asia Pacific Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 181: Rest of Asia Pacific Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 182: Rest of Asia Pacific Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 183: Rest of Asia Pacific Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 184: Middle East and Africa Amyotrophic Lateral Sclerosis Market Size, By Value, 2020H-2030F (USD Million)
Figure 185: Middle East and Africa Amyotrophic Lateral Sclerosis Market Share, By Drug, 2023 (%)
Figure 186: Middle East and Africa Amyotrophic Lateral Sclerosis Market Share, By New Product Launches, 2023 (%)
Figure 187: Middle East and Africa Amyotrophic Lateral Sclerosis Market Share, By Company, 2023 (%)
Figure 188: Middle East and Africa Amyotrophic Lateral Sclerosis Market CAGR (%), By Region, 2020-2023, 2025-2030
Figure 189: Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Medications, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 190: Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Respiratory Therapy, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 191: Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Speech Therapy, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 192: Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Physical Therapy, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 193: Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Other Treatment Types, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 194: Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Edaravone, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 195: Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Nuedexta, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 196: Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Riluzole, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 197: Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Other Drugs, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 198: Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Online Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 199: Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Retail Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 200: GCC Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 201: GCC Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 202: GCC Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 203: GCC Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 204: GCC Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 205: Israel Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 206: Israel Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 207: Israel Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 208: Israel Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 209: Israel Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 210: South Africa Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 211: South Africa Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 212: South Africa Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 213: South Africa Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 214: South Africa Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 215: Rest of Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 216: Rest of Middle East and Africa Amyotrophic Lateral Sclerosis Market Value, By Distribution Channel, 2023 (USD Million)
Figure 217: Rest of Middle East and Africa Amyotrophic Lateral Sclerosis Market Share, By Treatment Type, By Value, 2023 (%)
Figure 218: Rest of Middle East and Africa Amyotrophic Lateral Sclerosis Market Share, By Drug, By Value, 2023 (%)
Figure 219: Rest of Middle East and Africa Amyotrophic Lateral Sclerosis Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 220: Market Share of Prominent Companies of Global Amyotrophic Lateral Sclerosis Market, 2023 (%)
List of Tables
Table A1: Global Impact of Macro Economic Factors, By Region
Table A2: United States Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A3: United States Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A4: United States Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A5: United States Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A6: United States Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A7: United States Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A8: Canada Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A9: Canada Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024- 2030 (USD Million)
Table A10: Canada Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A11: Canada Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A12: Canada Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A13: Canada Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A14: Brazil Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A15: Brazil Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A16: Brazil Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A17: Brazil Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A18: Brazil Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A19: Brazil Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A20: Mexico Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A21: Mexico Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A22: Mexico Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A23: Mexico Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A24: Mexico Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A25: Mexico Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A26: Rest of Americas Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A27: Rest of Americas Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A28: Rest of Americas Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A29: Rest of Americas Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A30: Rest of Americas Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A31: Rest of Americas Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A32: Russia Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A33: Russia Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A34: Russia Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A35: Russia Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A36: Russia Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A37: Russia Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A38: France Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A39: France Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A40: France Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A41: France Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A42: France Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A43: France Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A44: United Kingdom Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A45: United Kingdom Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A46: United Kingdom Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A47: United Kingdom Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A48: United Kingdom Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A49: United Kingdom Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A50: Germany Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A51: Germany Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A52: Germany Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A53: Germany Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A54: Germany Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A55: Germany Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A56: Italy Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A57: Italy Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A58: Italy Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A59: Italy Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A60: Italy Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A61: Italy Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A62: Spain Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A63: Spain Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A64: Spain Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A65: Spain Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A66: Spain Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A67: Spain Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A68: Turkey Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A69: Turkey Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A70: Turkey Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A71: Turkey Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A72: Turkey Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A73: Turkey Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A74: Rest of Europe Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A75: Rest of Europe Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A76: Rest of Europe Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A77: Rest of Europe Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A78: Rest of Europe Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A79: Rest of Europe Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A80: China Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A81: China Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A82: China Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A83: China Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A84: China Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A85: China Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A86: India Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A87: India Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A88: India Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A89: India Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A90: India Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A91: India Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A92: South Korea Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A93: South Korea Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A94: South Korea Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A95: South Korea Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A96: South Korea Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A97: South Korea Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A98: Japan Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A99: Japan Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A100: Japan Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A101: Japan Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A102: Japan Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A103: Japan Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A104: Singapore Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A105: Singapore Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A106: Singapore Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A107: Singapore Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A108: Singapore Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A109: Singapore Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A110: Indonesia Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A111: Indonesia Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A112: Indonesia Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A113: Indonesia Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A114: Indonesia Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A115: Indonesia Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A116: Rest of Asia Pacific Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A117: Rest of Asia Pacific Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A118: Rest of Asia Pacific Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A119: Rest of Asia Pacific Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A120: Rest of Asia Pacific Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A121: Rest of Asia Pacific Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A122: GCC Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A123: GCC Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A124: GCC Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A125: GCC Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A126: GCC Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A127: GCC Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A128: Israel Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A129: Israel Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A130: Israel Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A131: Israel Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A132: Israel Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A133: Israel Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A134: South Africa Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A135: South Africa Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A136: South Africa Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A137: South Africa Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A138: South Africa Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A139: South Africa Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A140: Rest of Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A141: Rest of Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A142: Rest of Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A143: Rest of Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A144: Rest of Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A145: Rest of Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A2: United States Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A3: United States Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A4: United States Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A5: United States Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A6: United States Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A7: United States Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A8: Canada Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A9: Canada Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024- 2030 (USD Million)
Table A10: Canada Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A11: Canada Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A12: Canada Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A13: Canada Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A14: Brazil Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A15: Brazil Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A16: Brazil Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A17: Brazil Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A18: Brazil Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A19: Brazil Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A20: Mexico Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A21: Mexico Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A22: Mexico Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A23: Mexico Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A24: Mexico Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A25: Mexico Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A26: Rest of Americas Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A27: Rest of Americas Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A28: Rest of Americas Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A29: Rest of Americas Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A30: Rest of Americas Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A31: Rest of Americas Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A32: Russia Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A33: Russia Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A34: Russia Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A35: Russia Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A36: Russia Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A37: Russia Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A38: France Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A39: France Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A40: France Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A41: France Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A42: France Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A43: France Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A44: United Kingdom Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A45: United Kingdom Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A46: United Kingdom Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A47: United Kingdom Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A48: United Kingdom Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A49: United Kingdom Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A50: Germany Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A51: Germany Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A52: Germany Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A53: Germany Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A54: Germany Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A55: Germany Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A56: Italy Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A57: Italy Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A58: Italy Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A59: Italy Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A60: Italy Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A61: Italy Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A62: Spain Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A63: Spain Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A64: Spain Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A65: Spain Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A66: Spain Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A67: Spain Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A68: Turkey Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A69: Turkey Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A70: Turkey Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A71: Turkey Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A72: Turkey Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A73: Turkey Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A74: Rest of Europe Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A75: Rest of Europe Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A76: Rest of Europe Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A77: Rest of Europe Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A78: Rest of Europe Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A79: Rest of Europe Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A80: China Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A81: China Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A82: China Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A83: China Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A84: China Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A85: China Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A86: India Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A87: India Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A88: India Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A89: India Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A90: India Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A91: India Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A92: South Korea Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A93: South Korea Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A94: South Korea Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A95: South Korea Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A96: South Korea Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A97: South Korea Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A98: Japan Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A99: Japan Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A100: Japan Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A101: Japan Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A102: Japan Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A103: Japan Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A104: Singapore Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A105: Singapore Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A106: Singapore Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A107: Singapore Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A108: Singapore Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A109: Singapore Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A110: Indonesia Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A111: Indonesia Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A112: Indonesia Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A113: Indonesia Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A114: Indonesia Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A115: Indonesia Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A116: Rest of Asia Pacific Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A117: Rest of Asia Pacific Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A118: Rest of Asia Pacific Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A119: Rest of Asia Pacific Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A120: Rest of Asia Pacific Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A121: Rest of Asia Pacific Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A122: GCC Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A123: GCC Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A124: GCC Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A125: GCC Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A126: GCC Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A127: GCC Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A128: Israel Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A129: Israel Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A130: Israel Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A131: Israel Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A132: Israel Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A133: Israel Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A134: South Africa Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A135: South Africa Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A136: South Africa Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A137: South Africa Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A138: South Africa Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A139: South Africa Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A140: Rest of Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2020-2023 (USD Million)
Table A141: Rest of Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Treatment Type, By Value, 2024-2030 (USD Million)
Table A142: Rest of Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2020-2023 (USD Million)
Table A143: Rest of Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Drug, By Value, 2024-2030 (USD Million)
Table A144: Rest of Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A145: Rest of Middle East and Africa Amyotrophic Lateral Sclerosis Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Companies Mentioned
- Biohaven Pharmaceutical
- Ionis Pharmaceuticals, Inc.
- Sun Pharmaceutical
- BrainStorm Therapeutics
- F.Hoffmann-La Roche AG
- Mitsubishi Tanabe Pharma Corporation
- Biogen Inc.
- Corestem
- Otsuka Pharmaceutical Co., Ltd.
- AB Science
